Stock 1312 KONTAFARMA CHINA HOLDINGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Kontafarma China Holdings Limited

Equities

1312

KYG8918D1088

Pharmaceuticals

Market Closed - Hong Kong S.E.
Other stock markets
 09:08:35 22/05/2024 BST 		5-day change 1st Jan Change
0.038 HKD 0.00% Intraday chart for Kontafarma China Holdings Limited +8.57% +5.56%
05-02 Active Gains Files Winding-Up Petition Against Kontafarma China's Subsidiary MT
04-19 Kontafarma China Holdings Limited Announces Management Changes, Effect from 19 April 2024 CI

Business Summary

Kontafarma China Holdings Ltd, formely Tongfang Kontafarma Holdings Ltd, is an investment holding company principally engaged in pharmaceutical business. The Company operates its business through two business segments. The Pharmaceutical Business segment is engaged in the manufacture and sale of prescription drugs, including chemical drugs and prescribed traditional Chinese medicines, and laboratory related products. The Fitness Business is segment is engaged in the operation of fitness centers, the provision of consultation services for fitness and health activities, as well as the operation of the franchise business for royalty fee income.

Number of employees: 720

Sales per Business

HKD in Million2022Weight2023Weight Delta
Pharmaceutical
75.0 %
723 80.9 % 607 75.0 % -16.01%
Fitness
25.0 %
171 19.1 % 202 25.0 % +18.00%

Sales per region

HKD in Million2022Weight2023Weight Delta
China
73.2 %
715 80.0 % 592 73.2 % -17.14%
Singapore
20.1 %
133 14.9 % 163 20.1 % +22.08%
Taiwan
4.8 %
39 4.3 % 39 4.8 % +1.01%
Others
1.8 %
7 0.8 % 15 1.8 % +110.72%

Managers

Managers TitleAgeSince
Chao Wen Jiang CEO
 Chief Executive Officer 58 10/12/17
Man Wai Si Tou DFI
 Director of Finance/CFO 47 06/11/14
Jie Zhang COO
 Chief Operating Officer 41 02/09/20
Yu Huang BRD
 Director/Board Member 55 14/03/14

Members of the board

Members of the board TitleAgeSince
Sze Chung Chan BRD
 Director/Board Member 54 19/12/11
Rui Bin Zhang BRD
 Director/Board Member 52 23/07/14
Yu Huang BRD
 Director/Board Member 55 14/03/14
Jun Xi Zhang BRD
 Director/Board Member 60 20/08/15
Ping Yan Bai CHM
 Chairman 52 26/09/21
Chao Wen Jiang CEO
 Chief Executive Officer 58 10/12/17
Hong Jie Chai BRD
 Director/Board Member 50 02/09/20

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 5,588,571,777 1,901,799,777 ( 34.03 %) 0 34.03 %

Company contact information

Kontafarma China Holdings Ltd.

Sun Hung Kai Centre, 30 Harbor Road 12A09 - 12A20, 12A Floor

, Hong Kong

+

http://www.kontafarma.com.hk/en/index.php
address Kontafarma China Holdings Limited(1312)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
KONTAFARMA CHINA HOLDINGS LIMITED Stock Kontafarma China Holdings Limited
+5.56% 27.21M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+37.78% 723B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+31.59% 598B
JOHNSON & JOHNSON Stock Johnson & Johnson
-3.51% 364B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.94% 331B
ABBVIE INC. Stock AbbVie Inc.
+5.14% 288B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.45% 244B
ROCHE HOLDING AG Stock Roche Holding AG
-4.62% 208B
NOVARTIS AG Stock Novartis AG
+10.24% 210B
AMGEN INC. Stock Amgen Inc.
+9.32% 169B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 1312 Stock
  4. Company Kontafarma China Holdings Limited